GSK and CureVac are making 'next-generation' vaccines that they say can tackle multiple COVID-19 variants at once
The new GSK-CureVac mRNA vaccines will target coronavirus variants and could be available in 2022, if approved.
Full Article
GSK and CureVac are making 'next-generation' vaccines that they say can tackle multiple COVID-19 variants at once
Business Insider
0 shares
1 views
You might like
Related news coverage
UK backs CureVac effort to make vaccine for COVID variants
SeattlePI.com
LONDON (AP) —
The U.K. government says it will support a German biopharmaceutical company's effort to develop vaccines..
-
GSK, CureVac to make COVID-19 vaccines aimed at new variants
SeattlePI.com
-
Businessinsider.co.za | GSK, CureVac making 'next-generation' vaccines they say can tackle multiple Covid-19 variants at once
News24
-
GSK, CureVac to make COVID vaccines targeting new variants
SeattlePI.com
-
GSK and CureVac to develop vaccines to tackle Covid variants
FT.com